Literature DB >> 10764648

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

P Farci1, A Shimoda, A Coiana, G Diaz, G Peddis, J C Melpolder, A Strazzera, D Y Chien, S J Munoz, A Balestrieri, R H Purcell, H J Alter.   

Abstract

The mechanisms by which hepatitis C virus (HCV) induces chronic infection in the vast majority of infected individuals are unknown. Sequences within the HCV E1 and E2 envelope genes were analyzed during the acute phase of hepatitis C in 12 patients with different clinical outcomes. Acute resolving hepatitis was associated with relative evolutionary stasis of the heterogeneous viral population (quasispecies), whereas progressing hepatitis correlated with genetic evolution of HCV. Consistent with the hypothesis of selective pressure by the host immune system, the sequence changes occurred almost exclusively within the hypervariable region 1 of the E2 gene and were temporally correlated with antibody seroconversion. These data indicate that the evolutionary dynamics of the HCV quasispecies during the acute phase of hepatitis C predict whether the infection will resolve or become chronic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764648     DOI: 10.1126/science.288.5464.339

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  299 in total

1.  Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies.

Authors:  Wei-Kung Wang; Su-Ru Lin; Chao-Min Lee; Chwan-Chuen King; Shan-Chwen Chang
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus.

Authors:  N H Gruener; F Lechner; M C Jung; H Diepolder; T Gerlach; G Lauer; B Walker; J Sullivan; R Phillips; G R Pape; P Klenerman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Direct measurement of lymphocyte receptor diversity.

Authors:  Brenda M Ogle; Marilia Cascalho; Cristina Joao; William Taylor; Lori J West; Jeffrey L Platt
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

4.  Public versus personal serotypes of a viral quasispecies.

Authors:  Lukas Hunziker; Adrian Ciurea; Mike Recher; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

5.  Evolutionary potential of an RNA virus.

Authors:  Eugene V Makeyev; Dennis H Bamford
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Significance of pretreatment analysis of hepatitis C virus genotype 1b hypervariable region 1 sequences to predict antiviral outcome.

Authors:  Catherine Gaudy; Alain Moreau; Pascal Veillon; Stephanie Temoin; Francoise Lunel; Alain Goudeau
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

7.  In search of the correct strategy for preventing the spread of HCV infection.

Authors:  M Montella; A Crispo; J Wynn-Bellezza
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

8.  Role of genetic polymorphisms in hepatitis C virus chronic infection.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Caterina Sagnelli; Lorenzo Onorato; Evangelista Sagnelli
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

9.  Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system.

Authors:  Ana Maria Contreras; Yoichi Hiasa; Wenping He; Adam Terella; Emmett V Schmidt; Raymond T Chung
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Effect of ribavirin and amantadine on early hepatitis C virus RNA rebound and clearance in serum during daily high-dose interferon.

Authors:  Gerond Lake-Bakaar; Lynda Ruffini; Petr Kuzmic
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.